AstraZeneca · 9 hours ago
District Sales Manager, Advanced Specialty Care-Respiratory Biologics-Philadelphia, PA
AstraZeneca is a leading biopharmaceutical company focused on turning ideas into life-changing medicines. The Respiratory Biologic District Sales Manager will play a pivotal role in driving sales strategies and fostering collaborative partnerships to enhance patient outcomes in the Advanced Specialty Care Team.
BiopharmaBiotechnologyHealth CareMedicalPharmaceuticalPrecision Medicine
Responsibilities
Demonstrates strong understanding of advanced specialty pharmaceutical products, disease states, and treatment guidelines
Proactively guides and navigates teams through complex market and access challenges
Drives an account mindset, inclusive of comprehensive ecosystem dynamics, fostering collaborative partnerships
Ensures Brand alignment and strategies are incorporated into business plans
Actively engages in coaching and development of sales representatives to enhance their performance and professional growth, including in field with customer engagement
Cultivates a collaborative and performance-driven team environment, setting clear expectations and providing necessary support for sales representatives to excel
Drives growth opportunities, leveraging market insights and customer feedback to drive innovative sales strategies
Enables team to gain access via multiple selling channels across complex reimbursement models and accounts, leveraging relevant technology to achieve impact
Qualification
Required
Bachelor's Degree
3+ yrs Demonstrated Sales or Commercial experience or a combination of: pharmaceutical, healthcare, scientific, clinical, institutional, or related industry / settings within the healthcare ecosystem
Required experience in account management and/or complex reimbursement model OR Internal certification
Proven leadership capabilities and/or people management experience
A valid driver's license and safe driving record
Company
AstraZeneca
AstraZeneca is a pharmaceutical company that discovers, develops, manufactures, and markets prescription medicines. It is a sub-organization of Investor.
Funding
Current Stage
Public CompanyTotal Funding
$5.26B2024-07-30Post Ipo Debt· $1.51B
2023-02-28Post Ipo Debt· $2.25B
2023-02-24Post Ipo Debt· $1.5B
Leadership Team
Recent News
FierceBiotech
2026-02-04
2026-02-04
Longevity.Technology
2026-02-04
Company data provided by crunchbase